Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Revenue (2017 - 2025)

Inspire Medical Systems' Revenue history spans 9 years, with the latest figure at $269.1 million for Q4 2025.

  • For Q4 2025, Revenue rose 12.25% year-over-year to $269.1 million; the TTM value through Dec 2025 reached $912.0 million, up 13.6%, while the annual FY2025 figure was $912.0 million, 13.6% up from the prior year.
  • Revenue for Q4 2025 was $269.1 million at Inspire Medical Systems, up from $224.5 million in the prior quarter.
  • Across five years, Revenue topped out at $269.1 million in Q4 2025 and bottomed at $40.4 million in Q1 2021.
  • The 5-year median for Revenue is $152.2 million (2023), against an average of $149.0 million.
  • The largest annual shift saw Revenue surged 334.7% in 2021 before it rose 10.49% in 2025.
  • A 5-year view of Revenue shows it stood at $78.4 million in 2021, then skyrocketed by 75.9% to $137.9 million in 2022, then surged by 39.6% to $192.5 million in 2023, then increased by 24.52% to $239.7 million in 2024, then rose by 12.25% to $269.1 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Revenue are $269.1 million (Q4 2025), $224.5 million (Q3 2025), and $217.1 million (Q2 2025).